A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical ...

Cervical cancer is the third most common gynecological cancer in the United States, but a Louisville doctor says it can be ...

The health ministry is planning to include the Human papillomavirus (HPV) vaccination in the country’s immunization program ...

The vaccine is most effective when administered before any exposure to HPV. Here we debunk some of the most common myths ...

HPV can cause a variety of cancers, including cervical. New mortality data for women under 25 point to the success of the HPV vaccine.

The Alabama Department of Public Health reports that there are 14,000 new HPV cases annually and 4,000 women die from the disease each year.

“Whether you tell your partner is entirely your decision,” says Pisal. “Most men and women with HPV carry the infection ...

Cervical cancer is often highly treatable, with a five-year relative survival rate of 91% for localised, early-stage disease.

The quadrivalent HPV vaccine, developed by multinational pharmaceutical company Merck, was approved on Jan 8 for males on the Chinese mainland. The vaccine targets HPV types 6, 11, 16 and 18. The ...

A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II clinical trial.